|
|
| SN |
Author |
Title |
Status |
| 2601 |
mudassar |
DIAGNOSTIC ACCURACY OF DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING IN DIAGNOSING MUSCLE INVASION IN URINARY BLADDER CANCER, TAKING HISTOPATHOLOGY AS GOLD STANDARD |
Accepted |
| 2602 |
Monday K. Sapira |
THE RISK OF SPREAD OF PRIMARY PROSTATE CANCER IN PATIENTS WITH THE DISEASE IN PORT HARCOURT, NIGER DELTA REGION OF SOUTHERN NIGERIA. |
Accepted |
| 2603 |
Mokhtar |
CHEMICAL INCOMPATIBILITIES OF I.V ADMIXTURE COMBINATIONS IN ICU, ORTHOPEDIC AND EMERGENCY UNITS OF VARIOUS HOSPITALS AND MEDICAL CENTERS IN SANA’A, YEMEN |
Accepted |
| 2604 |
Ayesha |
INFLAMMATORY BOWEL DISEASE-AN OBSERVATIONAL STUDY ON RISK FACTORS AND MEDICATION MANAGEMENT |
Accepted |
| 2605 |
Narendra varma J |
A CROSS-SECTIONAL STUDY ON DRUG UTILIZATION AND IT’S COST ANALYSIS IN THE UROLOGY DEPARTMENT OF A TERTIARY CARE HOSPITAL |
Under Review |
| 2606 |
Md.Yousuf |
CLINICO-RADIOLOGICAL OUTCOME OF
PERCUTANEOUS VERTEBROPLASTY IN DORSO-LUMBAR
OSTEOPOROTIC VERTEBRAL COMPRESSION FRACTURES (OVCFS)
|
Accepted |
| 2607 |
Suresha D.N. |
NOVEL UV-SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF AMLODIPINE IN BULK AND PHARMACEUTICAL FORMULATION |
Accepted |
| 2608 |
Deepak |
"RASAYANA CHIKITSA: THE ANCIENT ART OF REJUVENATION AND OVERALL WELLNESS" |
Under Review |
| 2609 |
Mohamad Y. Rezk |
ROLE OF ASPROSIN IN OBESITY, DIABETES, AND METABOLIC SYNDROME |
Accepted |
| 2610 |
Anjali |
SIMILARITY BASED DESIGN, SYNTHESIS AND CHARACTERIZATION OF ISONIAZID ANALOGUES AND THEIR THERAPEUTIC POTENTIAL |
Under Review |
| 2611 |
Sonam Rawat |
ROLE OF PATHYA – APATHYAG IN VATARAKTA
W.S.R TO GOUT
|
Accepted |
| 2612 |
Ambikaprasad |
DANTOTPATTI: A CONCEPTUAL STUDY |
Accepted |
| 2613 |
Pursora Alok Singh |
AYURVEDIC APPROACH TO RHEUMATOID ARTHRITIS |
Accepted |
| 2614 |
Nikita Rolekar |
STUDY ON IMPACT OF SKIN REHABILITATION MASSAGE THERAPY ON IMMATURE SCAR IN BURN VICTIM |
Accepted |
| 2615 |
Ilakkiya |
MORPHOLOGY OF CORONARY SINUS OSTIUM AND THEBESIAN VALVE |
Accepted |
| 2616 |
Humayra Rumu |
EFFECTIVENESS OF ZINC SUPPLEMENTATION WITH TOPICAL RETINOIDS IN ACNE VULGARIS PATIENTS: A RANDOMIZED, DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL |
Accepted |
| 2617 |
Sumayra Jhumu |
EVALUATION OF SERUM LIPID PROFILE IN POSTMENOPAUSAL WOMEN |
Accepted |
| 2618 |
Danyalakshmi P.G.S. |
ADVANCES IN GOUT MANAGEMENT: FOCUS ON PREVALENCE, IMAGING, AND TARGETED TREATMENT APPROACHES |
Accepted |
| 2619 |
Ravindra Babu |
A COMPARATIVE STUDY ON CLINICO-ETIOLOGICAL PROFILE AND MANAGEMENT OF HYPONATREMIA IN TERTIARY CARE HOSPITAL |
Accepted |
| 2620 |
Meeval |
CASE REPORT ON RODENTICIDE POISONING |
Accepted |
| 2621 |
Tejaswini Ummiti |
REVIEW ARTICLE ON ORODISPERSIBLE TABLETS |
Under Review |
| 2622 |
Priyansh |
THE ROLE OF AYURVEDA IN WELLNESS TOURISM: ANCIENT WISDOM FOR MODERN WELL-BEING
|
Accepted |
| 2623 |
Melese Alemu |
MAJOR REPRODUCTIVE HEALTH PROBLEMS OF DAIRY CATTLE IN ETHIOPIA: A REVIEW |
Under Review |
| 2624 |
Padmini H.N. |
DESIGN EXPERT SUPPORTED MATHEMATICAL OPTIMIZATION OF METFORMIN HYDROCHLORIDE TABLETS: INVITRO EVALUATION |
Under Review |
| 2625 |
Gnamien Marcel |
Anticandidosis activity of aqueous and ethanolic extracts of Harungana madagascariensis, Zanthoxylum leprieurii and Xylopia aethiopica. |
Under Review |
| 2626 |
A. Myna |
METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF TRAMETINIB IN API FORM AND MARKETED TABLET DOSAGE FORM BY RP-HPLC |
Accepted |
| 2627 |
B.Sai Sree Vardhan |
“INDUCED PLURIPOTENT STEM CELL THERAPY IN PARKINSON DISEASE ”:EXPLORING BENEFITS , COST AND RISK |
Accepted |
| 2628 |
S.Lakshmi Sai Lahari |
IMPROVE PATIENT ENGAGEMENT AND HEALTH OUTCOMES THROUGH DATA- DRIVEN METHODOLOGY |
Accepted |
| 2629 |
SURUCHI |
A Review On Cleaning Validation Used In Pharmaceutical Industry |
Under Review |
| 2630 |
Mahmoud M.Alburyhi |
FORMULATION AND DEVELOPMENT OF FAMOTIDINE ORODISPERSIBLE TABLETS |
Accepted |
| 2631 |
Bhavya K.B. |
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF VALACYLOVIR BY: REVIEW |
Accepted |
| 2632 |
beeula |
IMPORTANCE OF SALIVARY PROTEINS AND ENZYMES IN ORAL CAVITY - A REVIEW |
Accepted |
| 2633 |
S. Lakshmi Sai Lahar |
IMPROVE PATIENT ENGAGEMENT AND HEALTH OUTCOMES THROUGH DATA-DRIVEN METHODOLOGY |
Under Review |
| 2634 |
Pavan Kumar |
DELVING INTO THE COLLECTIVE AWARENESS AND ATTITUDE TOWARDS MEDICINE AMONG THE RURAL POPULATION: A COMMUNITY SURVEY |
Accepted |
| 2635 |
Mounika Metta |
BRIDGING THE GAP: COMPUTATIONAL APPROACHES FOR INTEGRATING MEDICAL DATA AND INFORMATICS |
Accepted |
| 2636 |
Sakshi |
Uterine didelphys with Obstructed Hemivagina and Ipsilateral Renal Anomaly: OHVIRA SYNDROME – A Case Report |
Accepted |
| 2637 |
Juveriya Sulthana |
A REVIEW ARTICLE ON INFERTILITY IN MALES AND FEMALE |
Accepted |
| 2638 |
Jaipal |
REVIEW ARTICLE ON KAPHAJA KASA AND ITS AYURVEDIC MANAGEMENT |
Accepted |
| 2639 |
Fareed |
ASSESSMENT OF RIFLE CRITERIA IN TERITIARY CARE HOSPITALS |
Under Review |
| 2640 |
SHANKI |
IMPACT OF JUNK FOOD ON CHILDREN |
Accepted |
| 2641 |
SHANKI |
IMPACT OF JUNK FOOD ON CHILDREN |
Under Review |
| 2642 |
LUCRECE MARCELLINE |
AN ALGORITHMIC APPROACH TO THE MOLECULAR DIAGNOSIS OF ALPHA THALASSEMIA MUTATIONS IN GABONESE PATIENTS WITH SICKLE CELL TRAIT |
Accepted |
| 2643 |
Vishaka Kulkarni |
EVALUATION OF ANTIOBESITY ACTIVITY OF METHANOLIC EXTRACT OF CARALLUMA TUBERCULATA AERIAL PARTS ON HIGH FAT DIET-INDUCED OBESE WISTAR RATS
|
Accepted |
| 2644 |
Mogal Bhushan B. |
IN VIVO - ACUTE ORAL TOXICITY STUDY OF
RAS SINDOOR IN ALBINO RATS.
|
Accepted |
| 2645 |
Sarah |
EFFICIENCY OF DIFFERENT INTERNAL BLEACHING TECHNIQUES ON DISCOLORED TEETH:IN VITRO STUDY |
Accepted |
| 2646 |
Karin |
AN IN-DEPTH INTRODUCTION TO COOKING WITH SALT BLOCKS |
Under Review |
| 2647 |
Pratha |
A LITERARY REVIEW ON VISHAGHNA (ANTI-TOXIC) PROPERTY OF GAIRIKA (RED OCHRE) |
Accepted |
| 2648 |
Gitarani Choubey |
COVID-19 PANDEMIC AND RESEARCH IN ODISHA |
Accepted |
| 2649 |
Nasir Khan |
ASSESSMENT OF PREOPERATIVE ANXIETY IN PATIENTS UNDERGOING MAJOR GENERAL SURGERIES |
Under Review |
| 2650 |
Merugu Mahesh |
A NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF NILOTINIB IN BULK AND PHARMACEUTICAL FORMULATIONS |
Accepted |
|
|
SJIF Impact Factor: 7.065
